Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. news
  3. brain imaging
Show results for

Refine by
Date

  • This Year
  • Older

Brain Imaging Articles & Analysis

23 news found

Ace Therapeutics Accelerates Preclinical Depression Investigation by Providing Depression-Related Behavior Tests

Ace Therapeutics Accelerates Preclinical Depression Investigation by Providing Depression-Related Behavior Tests

In addition to depression behavior testing services, Ace Therapeutics also provides drug safety and efficacy studies, new antidepressant development, biomarker-based diagnostic development, and brain imaging diagnostic development, all to facilitate the research on depression, deepen understanding, and ultimately contribute to more effective treatments and ...

ByAce Therapeutics


Synaptive Medical to Test New Software for Brain Surgery Planning at Unity Health Toronto

Synaptive Medical to Test New Software for Brain Surgery Planning at Unity Health Toronto

Planning brain surgery is a delicate process that requires precision to avoid damaging surrounding brain tissue and to prevent post-surgery complications. ...

BySynaptive Medical


SpinTech CEO Presents STAGE at MedTech Strategist Innovation San Francisco 2021

SpinTech CEO Presents STAGE at MedTech Strategist Innovation San Francisco 2021

Ward Detwiler, our President & CEO, had the opportunity to speak about how STAGE is innovating the world of MR at MedTech Strategist Innovation 2021. ...

BySpinTech, Inc.


Pivalate’s additional data released from positive Phase II imaging trial in brain metastases

Pivalate’s additional data released from positive Phase II imaging trial in brain metastases

Sydney, Australia - November 23, 2022 - Radiopharm Theranostics (ASX:RAD), a developer of a world-class platform of radiopharmaceutical products for both diagnostic and therapeutic uses, is pleased to announce that Imperial College London has released additional data related to the F-18 Pivalate (RAD 101) Phase 2a imaging trial in patients with brain metastases. ...

ByRadiopharm Theranostics


Longeveron Publishes Peer Reviewed Study of Phase 1 Trial Results of Lomecel-B for Alzheimer’s Disease in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association

Longeveron Publishes Peer Reviewed Study of Phase 1 Trial Results of Lomecel-B for Alzheimer’s Disease in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association

Importantly, patients receiving Lomecel-B were not reported to develop a serious side-effect called amyloid-related imaging abnormalities (ARIA) as assessed by magnetic resonance imaging (MRI). ...

ByLongeveron, Inc.


Inscopix Expands Strategic Partnership with GRINTECH to Become Exclusive Global Supplier of GRIN lenses

Inscopix Expands Strategic Partnership with GRINTECH to Become Exclusive Global Supplier of GRIN lenses

Inscopix, Inc., a neuroscience company helping decode the brain for tomorrow’s treatments, announced that it is expanding its strategic supplier partnership with leading gradient index (GRIN) lens manufacturer GRINTECH GmbH to be the sole exclusive seller of GRIN lenses for neuroscience research applications. ...

ByInscopix Inc.


Qynapse to Present New Evidence on the Value of QyScore for the Diagnosis and Monitoring of Multiple Sclerosis at ACTRIMS Forum 2022

Qynapse to Present New Evidence on the Value of QyScore for the Diagnosis and Monitoring of Multiple Sclerosis at ACTRIMS Forum 2022

The posters highlight Qynapse’s latest results with QyScore®, its commercially-available automated brain image analysis platform, demonstrating the reproducibility of its results and its value to inform the MS diagnostic standard. ...

ByQynapse


AI ‘Fingerprinting’ Fights Back Against Hard-to-Detect Cancers

AI ‘Fingerprinting’ Fights Back Against Hard-to-Detect Cancers

Chris Kent, CEO of Reveal Surgical, explained that the company uses Raman spectroscopy (which is an optical, non-invasive imaging technique) to “fingerprint” different types of tumors, allowing doctors to fingerprint a tissue sample and compare it to those on record via Reveal’s software. ...

ByReveal Surgical


Optina announces a US$2.1M investment from the Diagnostics Accelerator at the Alzheimer’s Drug Discovery Foundation (ADDF)

Optina announces a US$2.1M investment from the Diagnostics Accelerator at the Alzheimer’s Drug Discovery Foundation (ADDF)

Optina, an innovative diagnostics company, leader in retinal imaging, brain health and systemic disease detection, announces the closing of an up to US$2.1M investment from the Alzheimer’s Drug Discovery Foundation (ADDF). ...

ByOptina Diagnostics


M Health Fairview University of Minnesota Medical Center Receives First Hyperfine Portable MRI to Grow its Advanced Imaging Systems Offering

M Health Fairview University of Minnesota Medical Center Receives First Hyperfine Portable MRI to Grow its Advanced Imaging Systems Offering

Swoop® was designed to enable rapid diagnoses and treatment for every patient regardless of income, resources, or location, pushing the boundaries of conventional imaging technology and expanding patient access to life-saving care. In as little as 30 seconds after a Swoop scan, advanced artificial intelligence applications analyze and return annotated, segmented ...

ByHyperfine


Another good news for Deep01! Taiwan`s first AI product obtained marketing approval from Japan`s FDA

Another good news for Deep01! Taiwan`s first AI product obtained marketing approval from Japan`s FDA

Zhou Renhai, CEO of Deep01, said that in the field of AI medical care, Taiwan can make world-class products, and Deep01 is the best example. In the vertical field of brain CT imaging, Deep01 has achieved global leadership. The AI functions of Deep01 are more complete than those of overseas competitors, and the AI computing speed is nearly 10 times faster. In ...

ByDeep01 Limited


Hyperfine Closes Business Combination with HealthCor Catalio Acquisition Corp and Liminal Sciences, Will Begin Trading under the Ticker “HYPR” on the Nasdaq Global Market

Hyperfine Closes Business Combination with HealthCor Catalio Acquisition Corp and Liminal Sciences, Will Begin Trading under the Ticker “HYPR” on the Nasdaq Global Market

Hyperfine’s Swoop® Portable MR Imaging SystemTM is designed to address the limitations of current imaging technologies and make MRI for brain imaging accessible anytime, anywhere, to any patient. ...

ByHyperfine


Optina Diagnostics Closes an Oversubscribed Series-A Round of CA$24.8 million

Optina Diagnostics Closes an Oversubscribed Series-A Round of CA$24.8 million

2021 Optina, an innovative diagnostics company leading the field of Retinal Imaging, Brain Health and Systemic Diseases Diagnostics, announced today the closing of an CA$24.8 million Series A round of funding. ...

ByOptina Diagnostics


Publication of EXALT-1 Trial in Cancer Discovery Demonstrates First AI-Supported Functional Precision Medicine Platform to Improve Cancer Treatment Outcomes

Publication of EXALT-1 Trial in Cancer Discovery Demonstrates First AI-Supported Functional Precision Medicine Platform to Improve Cancer Treatment Outcomes

Its international outlook is one of its most important pillars and the research focus is centered on immunology, cancer research, imaging, brain research and cardiovascular diseases. www.meduniwien.ac.at/web/en Forward-Looking Statements This press release contains certain forward-looking statements within the meaning of the “safe harbor” provisions ...

ByExscientia


Oxford Brain Diagnostics establishes a research-based clinical MRI study in Japan to investigate how Cortical Disarray Measurement (CDM) analysis may support differential diagnosis and estimate disease severity in Dementia patients

Oxford Brain Diagnostics establishes a research-based clinical MRI study in Japan to investigate how Cortical Disarray Measurement (CDM) analysis may support differential diagnosis and estimate disease severity in Dementia patients

In Japan, clinical MRI scanners are available for the diagnosis and evaluation of dementia. Brain imaging by MRI is available for patients with dementia and the prodromal stages using standard health insurance. ...

ByOxford Brain Diagnostics Ltd.


How the brain-eye connection aims to make memory loss a souvenir

How the brain-eye connection aims to make memory loss a souvenir

This process may take years, and eventually requires invasive and costly tests like nuclear brain imaging such as a PET (positron-emission tomography) scan. But isn’t there a better way? That’s why the experts in imaging, engineering and artificial intelligence at Optina Diagnostics have been working for 6 years to find new ...

ByOptina Diagnostics


FUJIFILM VisualSonics Celebrates the First Installation of the Vevo F2 with Photoacoustics

FUJIFILM VisualSonics Celebrates the First Installation of the Vevo F2 with Photoacoustics

With full control over transmit profiles, researchers now have the power and freedom to develop and explore new imaging methods in a quick, iterative fashion—going beyond existing imaging modes. ...

ByFUJIFILM VisualSonics, Inc.


MassChallenge announces 30 digital health companies to join its 2019 cohort

MassChallenge announces 30 digital health companies to join its 2019 cohort

cNeuro is a clinical decision support tool that helps clinicians make quantitative assessments of brain images. DynamiCare is a platform focused on reducing substance abuse. ...

ByEpihunter NV


NFL & GE Announce Six Final Winners of $10 Million Head Health Challenge

NFL & GE Announce Six Final Winners of $10 Million Head Health Challenge

The winners were selected from an initial group of 16 challenge winners that were chosen from more than 400 entries from 27 countries, after having been reviewed and nominated by a panel of leading healthcare experts in brain research, imaging technologies, and advocates for advances in brain research. ...

ByGeneral Electric


Prenatal exposure to insecticide Chlorpyrifos linked to alterations in brain structure and cognition

Agriculture Even low to moderate levels of exposure to the insecticide chlorpyrifos during pregnancy may lead to long-term, potentially irreversible changes in the brain structure of the child, according to a new brain imaging study by researchers from the Columbia Center for Children's Environmental Health at the Mailman School of Public ...

ByNational Institute of Environmental Health Sciences (NIEHS)

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT